Archives - Monday 14 July 2008
Infinity Pharmaceuticals Pulls Plug on Treatment for Prostate Cancer
Published on Monday 14 July 2008 - 23:31 - http://www.xconomy.com/Infinity Pharmaceuticals, the Cambridge, MA-based developer of cancer drugs, said today it has halted enrollment in a mid-stage study of IPI-504 for patients with prostate cancer, after it didnt...
Infinity Provides Update On Phase 2 Signal-Finding Clinical Study of IPI-504 in Advanced Prostate Cancer
Published on Monday 14 July 2008 - 23:13 - http://www.primenewswire.com/CAMBRIDGE, Ma., July 14, 2008 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) today announced that it has decided to discontinue further enrollment in its Phase 2 single agent,...
Prostate Cancer Drug Can Prevent Bone Loss
Published on Monday 14 July 2008 - 21:03 - http://www.eontarionow.com/New York - Drug manufacture Amgen is reporting that their drug denosumab can prevent bone loss in men with prostate cancer. In a clinical trial involving 1,400 prostate cancer patients, the drug...
Drug prevents bone loss in prostate cancer: Amgen
Published on Monday 14 July 2008 - 20:36 - http://in.reuters.com/LOS ANGELES (Reuters) - In a study, Amgen Inc's experimental drug denosumab reduced the risk of osteoporosis and fracture in men being treated with prostate cancer medicines that can cause bone...
Mass. cancer survivor kayaking 1,700 miles
Published on Monday 14 July 2008 - 20:29 - http://www.dailyindia.com/A Massachusetts carpentry teacher says he is kayaking 1,700 miles from Chicago to New York to raise awareness about prostate cancer.
Mass. cancer survivor kayaking 1,700 miles
Published on Monday 14 July 2008 - 20:10 - http://www.upi.com/DETROIT, July 14 (UPI) -- A Massachusetts carpentry teacher says he is kayaking 1,700 miles from Chicago to New York to raise awareness about prostate cancer.
Amgen Drug Reduces Bone Loss In Prostate Cancer Patients
Published on Monday 14 July 2008 - 19:12 - http://www.chattershmatter.com/A new drug manufactured by Amgen has been shown to prevent bone loss in men with prostate cancer. The drug is called denosumab and in clinical trials on prostate cancer patients, proved to help...
Drug prevents bone loss in prostate cancer - Amgen
Published on Monday 14 July 2008 - 18:29 - http://www.healthcentral.com/Amgen Inc on Monday said that a trial of its experimental drug denosumab showed that it can prevent osteoporosis in men being treated with prostate cancer drugs that can cause bone loss.
Prostate cancer race helps raise awareness
Published on Monday 14 July 2008 - 18:20 - http://www.county29.net/Indianapolis – On Saturday, July 12th prostate cancer survivor Gary Thompson and 7 members of his 28-member team, rode their bikes from Noblesville, IN to
Amgen releases positive denosumab results
Published on Monday 14 July 2008 - 17:22 - http://www.fiercebiotech.com/Amgen is publishing positive data today for its closely watched Phase III trial of denosumab for the treatment of bone loss in men undergoing androgen deprivation therapy for non-metastatic...
